Extreme hemodilution in rabbits:: An in vitro and in vivo thrombelastographic® analysis

被引:29
作者
Nielsen, VG
Baird, MS
机构
[1] Univ Alabama, Dept Anesthesiol, Div Cardiothorac Anesthesia, Birmingham, AL 35249 USA
[2] Univ Alabama, Dept Anesthesiol, Div Anesthesiol Res, Birmingham, AL 35249 USA
关键词
D O I
10.1097/00000539-200003000-00008
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Isovolemic hemodilution is used to decrease the incidence of blood transfusions. However, the effects of the degree of hemodilution and the fluid used on hemostasis are controversial. We tested the hypothesis that hemodilution and the fluid administered would adversely alter Thrombelastographic(R) (Haemoscope, Skokie, IL) variables (reaction time, alpha angle and maximal amplitude). Conscious rabbits had blood sampled from ear arteries and diluted 0% or 75% in viiro with one of four solutions: 6% hetastarch in 0.9% NaCl, 5% human albumin in 0.9% NaCl, or balanced electrolyte solutions containing either 6% pentastarch or 6% hetastarch. Isoflurane-anesthetized rabbits were randomly assigned to groups (n = 9 per group) that underwent in vivo isovolemic hemodilution (75% of estimated blood volume removed), with blood replaced with one of the four solutions mentioned previously. In vitro hemodilution resulted in a significant (P < 0.05) decrease in hemostatic function (increase in reaction time, decrease in a angle and maximal amplitude) that was largest after hemodilution with albumin. However, although in vivo hemodilution significantly (P < 0.05) decreased reaction time, increased the a angle, and decreased maximal amplitude, there were no significant fluid-dependent effects. Implications: The effects of hemodilution and the fluid used on Thrombelastographic(R) (Haemoscope, Skokie, IL) variables are markedly different between in vitro and in vivo hemodilution studies.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 19 条
[1]   CALCIUM THRESHOLD IN HUMAN PLASMA CLOTTING KINETICS [J].
ATAULLAKHANOV, FI ;
POHILKO, AV ;
SINAURIDZE, EI ;
VOLKOVA, RI .
THROMBOSIS RESEARCH, 1994, 75 (04) :383-394
[2]   Evaluation of a new hydroxyethyl starch preparation (Hextend(TM)) on selected coagulation parameters [J].
Bick, RL .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (03) :215-229
[3]   Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation [J].
Egli, GA ;
Zollinger, A ;
Seifert, B ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
BRITISH JOURNAL OF ANAESTHESIA, 1997, 78 (06) :684-689
[4]   Hextend®, a physiologically balanced plasma expander for large volume use in major surgery:: A randomized phase III clinical trial [J].
Gan, TJ ;
Bennett-Guerrero, E ;
Phillips-Bute, B ;
Wakeling, H ;
Moskowitz, DM ;
Olufolabi, Y ;
Konstadt, SN ;
Bradford, C ;
Glass, PSA ;
Machin, SJ ;
Mythen, MG .
ANESTHESIA AND ANALGESIA, 1999, 88 (05) :992-998
[5]  
GELMAN S, 1987, ANESTH ANALG, V66, P936
[6]   GENERAL-ANESTHESIA AND HEPATIC CIRCULATION [J].
GELMAN, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1987, 65 (08) :1762-1779
[7]   The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation [J].
Jamnicki, M ;
Zollinger, A ;
Seifert, B ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
ANAESTHESIA, 1998, 53 (07) :638-644
[8]   Compromised blood coagulation:: An in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thromboelastography [J].
Jamnicki, M ;
Zollinger, A ;
Seifert, B ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
ANESTHESIA AND ANALGESIA, 1998, 87 (05) :989-993
[9]  
KIM HW, 1992, SURG GYNECOL OBSTET, V175, P219
[10]   EFFECT OF HYDROXYETHYL STARCH AND DEXTRAN ON PLASMA-VOLUME AND BLOOD HEMOSTASIS AND COAGULATION [J].
KORTTILA, K ;
GROHN, P ;
GORDIN, A ;
SUNDBERG, S ;
SALO, H ;
NISSINEN, E ;
MATTILA, MAK .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (07) :273-282